Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers

European Journal of Human Genetics

Volumn 20, Issue 5, 2012, Pages 547-551

  Heald, Brandie ^a,b   Edelman, Emily ^a,b   Eng, Charis ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer; colon cancer; Navigenics; prostate cancer; risk assessment

Indexed keywords

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; COLORECTAL CANCER; FAMILY HISTORY; FAMILY HISTORY BASED RISK ASSESSMENT; FEMALE; GENETIC RISK; GENETIC SCREENING; HUMAN; HUMAN GENOME; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84859910130     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.224     Document Type: Article

References (30)

1. Sorensen TI, Nielsen GG, Andersen PK, Teasdalte TW: Genetic and environmental influences on premature mortality in adult adoptees. N Engl J Med 1988; 318: 727-732. (Pubitemid 18090256)
2. Petersen L, Nielsen GG, Andersen PK, Sorensen TI: Case-control study of genetic and environmental influences of premature death of adult adoptees. Genet Epidemiol 2002; 23: 123-132. (Pubitemid 34982040)
3. Eng C, Sharp RR: Bioethical and clinical dilemmas of direct-to-consumer genomic testing: the problem of misattributed equivalance. Science Transl Med 2010; 2: 1-5.
4. McGuire AL, Burke W: An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA 2008; 300: 2669-2671.
5. Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, Khoury MJ: Can family history be used as a tool for public health and preventive medicine? Genet Med 2002; 4: 304-310.
6. Lichtenstein P, Holm N, Verkasalo P et al: Environmental and heritable factors in the causation of cancer. N Engl J Med 2000; 343: 78-85.
7. Guttmacher AE, Collins FS, Carmona RH: The family history - more important than ever. N Engl J Med 2004; 351: 2333-2336. (Pubitemid 39552752)
8. Kloos RT, Eng C, Evans DB et al: Medullary thyroid carcinoma: Management Guidelines of the American Thyroid Association. Thyroid 2009; 19: 565-612.
9. Zbuk K, Eng C: Cancer phenomics: RET and PTEN as illustrative models. Nature Rev Cancer 2007; 7: 35-45. (Pubitemid 46020845)
10. Scheuner MT, Wang SJ, Raffel LJ, Larabell SK, Rotter JI: Family history: a comprehensive genetic risk assessment method for the chornic conditions of adulthood. Am J Med Genet 1997; 71: 315-324. (Pubitemid 27330107)
11. Gail MH, Brinton LA, Byar DP et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81: 1879-1886. (Pubitemid 20026073)
12. Claus EB, Risch N, Thompson WB: The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat 1993; 28: 115-120. (Pubitemid 24056083)
13. Eng C: Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 2000; 37: 828-830.
14. Li FP, Fraumeni Jr JF: Collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome. Cancer Epidemiol Biomark Prevent 1994; 3: 715-717. (Pubitemid 24377966)
15. Varley JM, McGown G, Thorncroft M et al: Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 1997; 57: 3245-3252. (Pubitemid 27351742)
16. Eeles RA: Germline mutations in the TP53 gene. Cancer Surv 1995; 25: 101-124.
17. Brooks-Wilson AR, Kaurah P, Suriano G et al: Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004; 41: 508-517. (Pubitemid 38932110)
18. Giardello FM, Walsh SB, Hamiton SR et al: Increased risk of cancer in Peutz-Jeghers syndrome. N Engl J Med 1987; 316: 1511-1514.
19. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC: Mendelian inheritance in familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367-3371.
20. Vasen HF, Watson P, Mecklin J-P, Lynch HT: New clinical criteria for hereditary non-polyposis colon cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999; 116: 1453-1456. (Pubitemid 29258894)
21. Umar A, Boland CR, Terdiman JP et al: Revised Bethesda guidelines for hereditary nonpolyposis colon cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-268. (Pubitemid 38256271)
22. Nielsen M, Hes FJ, Nagengast FM et al: Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 2007; 71: 427-433. (Pubitemid 46730652)
23. APC-associated polyposis conditions, 2009. http://www.ncbi.nlm.nih.gov/ books/ NBK1345/. (Accessed 24 August 2009).
24. Sieber OM, Lipton L, Crabtree M et al: Multiple colorectal adenomas, classic adenomatous polyposis and germ-line mutations in MYH. N Engl J Med 2003; 348: 791-799. (Pubitemid 36245755)
25. Jass JR, Williams CB, Bussey HJR, Morson BC: Juvenile polyposis-a precancerous condition. Histopathology 1988; 13: 619-630.
26. Edelman E, Eng C: A practical guide to the interpretation and clinical application of personal genomic screening. Br Med J 2009; 339: b4253.
27. Eng C: Mendelian genetics of rare-and not so rare-cancers. Ann NY Acad Sci 2010; 1214: 70-82.
28. Osorio A, Milne RL, Pita G et al: Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Br J Cancer 2009; 101: 2048-2054.
29. Antoniou AC, Spurdle AB, Sinilnikova OM et al: Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008; 82: 937-948.
30. Xu J, Sun J, Kader AK et al: Estimation of absolute risk for prostate cancer using genetic markers and family history. Prostate 2009; 69: 1562-1572.